Form 4: Novanta CEO Sells Shares Under Pre-Planned 10b5-1

Novanta Inc.'s CEO, Matthijs Glastra, sold 6,177 shares of common stock for $130 per share on January 9, 2026, under a pre-established 10b5-1 trading plan.

Summary

• Matthijs Glastra, the Chief Executive Officer and a Director of Novanta Inc. (NOVT), reported the sale of common stock.
• The transaction involved the disposition of 6,177 shares of Novanta Inc. common stock.
• The shares were sold at a price of $130 per share, totaling approximately $802,010.
• The sale occurred on January 9, 2026, and was executed pursuant to a pre-established Rule 10b5-1 trading plan.
• The 10b5-1 trading plan was adopted on September 11, 2025, through a trust for which the reporting person's spouse is a trustee.
• Following this transaction, Matthijs Glastra directly owns 78,867 shares and indirectly owns 54,382 shares through the Matthijs Glastra 2021 Irrevocable Trust.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-established 10b5-1 trading plan, which typically indicates a planned liquidity event rather than a change in sentiment regarding the company's prospects. Therefore, the sentiment is neutral.

Related Party Transactions

• The sale was effected through a trust for which the reporting person's spouse is a trustee, indicating a related party in the context of beneficial ownership.

Stakeholder Impact

• Shareholders: A routine insider sale under a 10b5-1 plan is generally not seen as a significant signal of future performance and typically has minimal impact on shareholder sentiment or share price.
• Employees: No direct impact.
• Customers, Suppliers, Creditors: No direct impact.

Key Dates

Keywords

Novanta Inc., NOVT, Matthijs Glastra, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, CEO, Director